Sarepta Therapeutics, Inc. SRPT, a developer of innovative RNA-based therapeutics, today announced that management is scheduled to present a company overview at the following investor conferences in March. Chris Garabedian, Sarepta's president and chief executive officer, will be the presenter.
- Cowen and Company 35th Annual Health Care Conference in Boston, MA on Monday, March 2 at 4:10 p.m. EST.
- 27th Annual ROTH Conference in Dana Point, CA on Monday, March 9 at 3:00 p.m. PST.
- Barclays Global Healthcare Conference 2015 in Miami Beach, FL on Thursday, March 12 at 1:35 p.m. EST.
The presentations will be webcast live on the investor relations section of the Sarepta Therapeutics website at www.sarepta.com and will be archived under the events and presentations section following each presentation for 90 days.
About Sarepta Therapeutics
Sarepta Therapeutics is
focused on developing first-in-class RNA-based therapeutics to improve
and save the lives of people affected by serious and life-threatening
rare and infectious diseases. The Company's diverse pipeline includes
its lead program eteplirsen, for Duchenne muscular dystrophy, as well as
potential treatments for some of the world's most lethal infectious
diseases. Sarepta aims to build a leading, independent biotech company
dedicated to translating its RNA-based science into transformational
therapeutics for patients who face significant unmet medical needs. For
more information, please visit us at www.sarepta.com.
Internet Posting of Information
We routinely post
information that may be important to investors in the 'For Investors'
section of our web site at www.sarepta.com.
We encourage investors and potential investors to consult our website
regularly for important information about us.
Media and Investors:
Sarepta Therapeutics, Inc.
Ian Estepan,
617-274-4052
iestepan@sarepta.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.